Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?
qimono / Pixabay

Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

Genetic testing, such as 23andMe, has been approved by the FDA for direct-to-consumer genetic testing.  However, this type of testing has not been approved to predict rheumatic diseases. Research is…

Continue Reading Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

Rare Diseases Could Be Diagnosed Earlier with Better Training for GPs to Avoid Years of Misdiagnosis

Although each disease on its own may be rare, a huge number of people are living with a rare disease-- and half of these people are children. About 30 percent of these children…

Continue Reading Rare Diseases Could Be Diagnosed Earlier with Better Training for GPs to Avoid Years of Misdiagnosis

The Argument for Mandatory Newborn Screening and Government Subsidies for Rare Diseases in India

The State of Rare Disease in India There are 7,000 known rare diseases worldwide. The Organization for Rare Diseases India (ORDI) estimates 70 million people are affected by a rare diagnosis…

Continue Reading The Argument for Mandatory Newborn Screening and Government Subsidies for Rare Diseases in India

New Potential Treatment for Systemic-Onset Juvenile Idiopathic Arthritis Investigated in China

SOJIA SOJIA stands for systemic-onset Juvenile Idiopathic Arthritis (JIV). It is a very severe form of JIA which causes joint pain, inflammation, recurrent fevers, and a skin rash. Patients often take predinsolone,…

Continue Reading New Potential Treatment for Systemic-Onset Juvenile Idiopathic Arthritis Investigated in China

4,800 People Waited for Hours in the Rain to See if They Were Eligible Stem Cell Donors for Little Boy with Rare Leukemia

On December 28, 2018, five-year-old Oscar Saxelby-Lee was diagnosed with a rare and aggressive form of leukemia. Now he's in a race against time to find an eligible stem cell…

Continue Reading 4,800 People Waited for Hours in the Rain to See if They Were Eligible Stem Cell Donors for Little Boy with Rare Leukemia

New Treatment for Familial Chylomicronemia Syndrome is Close to Approval in the EU

Familial Chylomicronemia Syndrome Familial chylomicronemia syndrome (FCS) is a condition that is considered ultra-rare. It's caused when the enzyme called lipoprotein lipase (LPL) is impaired. It is can result in…

Continue Reading New Treatment for Familial Chylomicronemia Syndrome is Close to Approval in the EU

Study Suggests that Spleen Artery Aneurysms May be more Common in Gaucher Disease than Previously Thought

According to a story from Gaucher Disease News, a recently published case report study suggests that instances of splenic artery aneurysm are being underreported in patients with Gaucher disease. The…

Continue Reading Study Suggests that Spleen Artery Aneurysms May be more Common in Gaucher Disease than Previously Thought
Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation
NeuPaddy / Pixabay

Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation

According to a story from Central Charts, the biopharmaceutical company Acceleron Pharma Inc. recently announced that the company's experimental drug candidate ACE-083 has earned Orphan Drug designation from the US…

Continue Reading Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation